Search Bar & Filters
Found 1 Actively Recruiting clinical trials
P
Actively Recruiting
Researchers are evaluating Veregen 10% ointment as a new herbal topical treatment for adults with mild to moderate Actinic Keratosis AK on the face and scalp. The study aims to show that Veregen ointment is superior to a placebo ointment in completely clearing a defined treatment area of AK lesions. This randomized, placebo-controlled, double-blind Phase 3 trial focuses on patients aged 18 and older with specific AK lesion characteristics.
1 location